Search Results 281-290 of 17159 for monoclonal antibody

  1. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  2. Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma - Mayo Clinic

    Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...

  3. Recurrent Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Epacadostat may stop the growth of tumor ...

  4. Trastuzumab-dkst (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-dkst is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  5. Tislelizumab-jsgr (intravenous route) - Side effects & uses - Mayo Clinic

    Tislelizumab-jsgr is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...

  6. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  7. Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study - Mayo Clinic

    Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. I. Participation eligibility. Participant ...

  8. Vedolizumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a monoclonal antibody that works on ...

  9. Sarosh R. Irani, B.M., B.Ch., D.Phil. - Mayo Clinic Faculty Profiles

    Cloned autoantigen-reactive monoclonal antibodies to re-create these diseases for research. Dr. Irani has supervised more than 50 international clinicians and ...

  10. Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...